Guaifenesin 400 MG / pseudoephedrine hydrochloride 40 MG Oral Tablet — RxCUI 1090623
RxNorm drug concept · Semantic clinical drug
RxCUI 1090623
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1090623
Official nameGuaifenesin 400 MG / pseudoephedrine hydrochloride 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asguaiFENesin 400 MG / pseudoephedrine HCl 40 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Guaifenesin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Guaifenesin doesn't suppress your cough — it actually makes it work better. It loosens and thins the mucus in your chest so your cough can move it out of your airways more effectiv...
- What exactly does guaifenesin do — does it actually stop my cough?
- No — extended-release tablets like 12 Hour Mucus Relief and 365 Whole Foods Market Guaifenesin must be swallowed whole. Crushing, chewing, or breaking them releases the medicine al...
- Can I crush or split the extended-release tablet to make it easier to swallow?
🕸️ Concept Web — How Guaifenesin 400 MG / pseudoephedrine hydrochlori... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Guaifenesin 400 MG / pseudoephedrine hydrochloride 40 MG Oral Tablet
RxCUI 1090623 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Guaifenesin
5032IN -
Pseudoephedrine
8896IN -
Guaifenesin / pseudoephedrine
214599MIN -
Pseudoephedrine hydrochloride
91168PIN
-
Guaifenesin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Guaifenesin / pseudoephedrine Oral Tablet
373691SCDF -
Guaifenesin / pseudoephedrine hydrochloride Oral Tablet
2646441SCDFP -
Guaifenesin / pseudoephedrine Oral Product
1159127SCDG -
Guaifenesin / pseudoephedrine Pill
1159128SCDG -
Guaifenesin / pseudoephedrine hydrochloride Oral Product
2659873SCDGP -
Guaifenesin / pseudoephedrine hydrochloride Pill
2659515SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Guaifenesin / pseudoephedrine Oral Tablet
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Guaifenesin 400 MG
316015SCDC -
Pseudoephedrine hydrochloride 40 MG
996717SCDC
-
Guaifenesin 400 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Guaifenesin 400 MG
SCDC · 316015 -
Pseudoephedrine hydrochloride 40 MG
SCDC · 996717 -
Guaifenesin / pseudoephedrine Oral Tablet
SCDF · 373691 -
Guaifenesin / pseudoephedrine hydrochloride Oral Tablet
SCDFP · 2646441 -
Guaifenesin / pseudoephedrine Oral Product
SCDG · 1159127 -
Guaifenesin / pseudoephedrine Pill
SCDG · 1159128 -
Guaifenesin / pseudoephedrine hydrochloride Oral Product
SCDGP · 2659873 -
Guaifenesin / pseudoephedrine hydrochloride Pill
SCDGP · 2659515
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1090623 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 41250-0547-72 | 3 BLISTER PACK in 1 CARTON (41250-547-72) / 9 TABLET, FILM... | Mucus Relief D | Meijer Distribution Inc | 2007-01-26 |
Observed labelers:
Meijer Distribution Inc (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.